azomycin has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, DP; Donohoe, DL; Mattson, DL; Roethe, K | 1 |
| Dulaney, EL; Frost, BM; Valiant, ME | 1 |
| Moore, MJ | 1 |
| Frey, FJ; Heizmann, E; Horber, FF; Maurer, O; Probst, PJ | 1 |
1 review(s) available for azomycin and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of cyclophosphamide.
Topics: Aldehyde Dehydrogenase; Animals; Cyclophosphamide; Humans; Kidney Diseases; Liver Diseases; Nitroimidazoles; Xanthines | 1991 |
3 other study(ies) available for azomycin and Kidney Diseases
| Article | Year |
|---|---|
Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage.
Topics: Acute Kidney Injury; Animals; Arginine; Chronic Disease; Disease Progression; Hypoxia; Ischemia; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Nephrectomy; Nitroimidazoles; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury; Time Factors | 2003 |
Antibacterial activity of 3-(1-methyl-5-nitro-2-imidazolylmethylideneamino)-2-oxazolidinone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Female; Furazolidone; Kidney Diseases; Male; Mice; Mice, Inbred Strains; Nitroimidazoles; Oxazoles; Rats; Rats, Inbred Strains | 1975 |
High haemodialysis clearance of ornidazole in the presence of a negligible renal clearance.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Nitroimidazoles; Ornidazole; Renal Dialysis | 1989 |